Showing results (21-30 of 70) with videos related to
Sort By:
Pageof 7
Lung Cancer (Amsterdam, Netherlands)|May 31, 2016
Palliative systemic therapy for advanced non-small cell lung cancer: Investigating disparities between patients who are treated versus those who are notStephanie Y Brule, Khalid Al-Baimani, Hannah Jonker, et al.Cancer|November 20, 2009
A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer: a trial of the NCIC Clinical Trials GroupScott A Laurie, Lillian L Siu, Eric Winquist, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
NCIC CTG IND.190 phase I trial of dalotuzumab (MK-0646) in combination with cisplatin and etoposide in extensive-stage small-cell lung cancerPeter M Ellis, Frances A Shepherd, Scott A Laurie, et al.Cancer|July 13, 2002
The clinical course of nonsmall cell lung carcinoma in survivors of Hodgkin diseaseScott A Laurie, Mark G Kris, Carol S Portlock, et al.Lung Cancer (Amsterdam, Netherlands)|September 30, 2015
Analysis of serum protein levels of angiogenic factors and their soluble receptors as markers of response to cediranib in the NCIC CTG BR.24 clinical trialChristina L Addison, Keyue Ding, Lesley Seymour, et al.Cancer Treatment Reviews|February 14, 2017
Biology and patterns of response to EGFR-inhibition in squamous cell cancers of the lung and head & neckRosalyn A Juergens, Scott V Bratman, Ming-Sound Tsao, et al.Journal of Translational Medicine|April 3, 2016
A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignanciesGlenwood D Goss, Derek J Jonker, Scott A Laurie, et al.Current Opinion in Molecular Therapeutics|February 6, 2004
Overview of phase I studies of intravenous administration of PV701, an oncolytic virusRobert M Lorence, Andrew L Pecora, Pierre P Major, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitizationScott A Laurie, John C Bell, Harold L Atkins, et al.Cancer Discovery|June 3, 2023
The MDM2-p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation StudyPatricia LoRusso, Noboru Yamamoto, Manish R Patel, et al.Pageof 7